SIM
ALDR

Spark Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Spark Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-161,000
Closed -$1.97M – 865
2017
Q3 		$1.97M Buy
+161,000
New +$1.68M 0.11% 267
2015
Q2 		– Sell
-74,900
Closed -$2.16M – 783
2015
Q1 		$2.16M Buy
74,900
+31,600
+73% +$867K 0.3% 92
2014
Q4 		$1.26M Buy
43,300
+4,900
+13% +$88K 0.21% 156
2014
Q3 		$486K Buy
38,400
+6,300
+20% +$95.2K 0.07% 359
2014
Q2 		$642K Buy
+32,100
New +$452K 0.1% 300

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spark Investment Management's ALDR Position: Q4 2017 in Review

Spark Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2017, closing a stake of 161,000 shares — an estimated $1.97M sold.

Spark Investment Management first reported a position in ALDR in Q2 2014 and held it in 5 quarters. The position peaked at $2.16M in Q1 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q4 2017.

  • Spark Investment Management reported no remaining Alder Biopharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Spark Investment Management sold 161,000 Alder Biopharmaceuticals shares in Q4 2017, an estimated $1.97M.
  • Spark Investment Management first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Spark Investment Management's Alder Biopharmaceuticals position peaked at $2.16M in Q1 2015.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2017.

Based on Spark Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.